AU2453697A - Use of photopheresis in the treatment of chronic infection by hepatitis c virus - Google Patents

Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Info

Publication number
AU2453697A
AU2453697A AU24536/97A AU2453697A AU2453697A AU 2453697 A AU2453697 A AU 2453697A AU 24536/97 A AU24536/97 A AU 24536/97A AU 2453697 A AU2453697 A AU 2453697A AU 2453697 A AU2453697 A AU 2453697A
Authority
AU
Australia
Prior art keywords
photopheresis
hepatitis
virus
treatment
chronic infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24536/97A
Inventor
Christopher B. O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU2453697A publication Critical patent/AU2453697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
AU24536/97A 1996-04-10 1997-04-10 Use of photopheresis in the treatment of chronic infection by hepatitis c virus Abandoned AU2453697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1522596P 1996-04-10 1996-04-10
US60015225 1996-04-10
PCT/US1997/005966 WO1997037654A1 (en) 1996-04-10 1997-04-10 Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Publications (1)

Publication Number Publication Date
AU2453697A true AU2453697A (en) 1997-10-29

Family

ID=21770194

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24536/97A Abandoned AU2453697A (en) 1996-04-10 1997-04-10 Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Country Status (2)

Country Link
AU (1) AU2453697A (en)
WO (1) WO1997037654A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000510003A (en) * 1996-03-29 2000-08-08 セラコス・インコーポレーテツド Photopheresis treatment of chronic HCV infection
IL126366A (en) * 1996-03-29 2011-10-31 Therakos Inc Use of a photoactivatable compound in the manufacture of a medicament for the treatment of an infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood

Also Published As

Publication number Publication date
WO1997037654A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
EP0707855A3 (en) Combination therapy for chronic hepatitis C infection
AU2064297A (en) Hepatitis c virus ribozymes
AU7846694A (en) Adjustable treatment chamber catheter
HK1037981A1 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis C.
AU3434393A (en) Targeted virus
AU2568800A (en) Tubing for extracorporal purification of the blood and use thereof
AU2550995A (en) Hepatitis c virus asialoglycoproteins
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
AU7567394A (en) Treatment chamber catheter
AU2158000A (en) Treatment of hepatitis c virus infections with interleukin-10
AU2549797A (en) Xanthone analogs for the treatment of infectious diseases
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU7099198A (en) Use of amantadine for treatment of hepatitis c
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
AU5758594A (en) Treatment of viral infections
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
AU2281601A (en) Treatment of viral infections using levovirinTM
AU5679394A (en) Hepatitis b virus vaccines
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU2453697A (en) Use of photopheresis in the treatment of chronic infection by hepatitis c virus
AU3530395A (en) Treatment of viral infections
FI965196A0 (en) Combination therapy for HIV infection
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection